"So if you include 100% of the sulphides then the spot valuation should be $24 per share."
Not so...The sulphides (50%) are quoted at $3.25ps. So if you take 100% of the sulphides the valuation becomes $15.25ps and not $24ps.
Any way you look at it CMR looks undervalued.
short trying to cover, page-19
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)